MedPath
TGA Approval

RYZODEG 70/30 FLEXTOUCH 70% insulin degludec (rys) / 30% insulin aspart (rys) 100 U/mL solution for injection cartridge (280432)

280432

RYZODEG 70/30 FLEXTOUCH 70% insulin degludec (rys) / 30% insulin aspart (rys) 100 U/mL solution for injection cartridge

Novo Nordisk Pharmaceuticals Pty Ltd

November 29, 2017

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/3bf80132a0161fb0f1c2ea59156867af.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/c6eafff46a69b0d9c2b795ae93ff082b.pdf

Active Ingredients

Insulin aspart

Insulin degludec

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

RYZODEG 70/30 FLEXTOUCH 70% insulin degludec (rys) / 30% insulin aspart (rys) 100 U/mL solution for injection cartridge (280432) - TGA 批准文号 | MedPath